{"nct_id":"NCT02413827","title":"A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma","status":"TERMINATED","status_verified_date":"2017-04","start_date":"2015-04","start_date_type":"ACTUAL","primary_completion_date":"2016-11-02","primary_completion_date_type":"ACTUAL","completion_date":"2016-11-09","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["CLDX"]}